Freedom Innovations competitors

Takaaki Ueda is a Chairman/CEO at SONOSITE INC, Pres & CEO:New Development USA at Fujifilm Holdings, and President/CEO at FUJIFILM Medical Systems USA Inc. He has worked as Gen Mgr:Global Endoscopy Systems at Fujifilm Holdings.

Wang Huanjie are a VP/Secretary at Valiant Co Ltd; Head:Synthesis Workshop at Yantai Valiant Fine Chemicals Co., Ltd; and Chief Executive Officer at MP Biomedicals. They have worked as Head:Planning Department at Yantai Valiant Fine Chemicals Co., Ltd; President Assistant at Yantai Valiant Fine Chemicals Co., Ltd; and VP/Secretary at Yantai Valiant Fine Chemicals Co., Ltd. Wang work or have worked as MEMBER at Communist Party of China.

Matthew Call is a Chief Executive Officer at Photomedex.

Dr. Krishan Kalra L. is a Chief Executive Officer at BIOGENEX LABORATORIES and is based in United States.

Accomplished Senior Executive with 20+ years of diverse healthcare market experience across the continuum of care: physician office, hospital, outpatient, integrated delivery networks (IDN), group purchasing (GPO), payer organizations, medical banking, retail and consumer directed healthcare. Demonstrated success in shaping corporate direction, designing and executing business strategies, building and leading sales and cross functional teams to deliver profitable results in a variety of corporate environments including: startup, rapid growth, turn-around, strategic repositioning and Fortune 100. Revenue responsibility for $1 million to $230 million enterprises. Extensive Board level interaction. Accomplishments include pioneering a first to market non-invasive medical technology, and a key role in a startup company's growth to $1 billion+ market valuation in six years (recognized by INC. Magazine as #1 Fastest Growing Company). Passion of a successful entrepreneur and the discipline of a seasoned executive. Specialties: B2B, B2C, B2B2C Start-up and early stage environment Commercialization strategies Implementation of complex healthcare technologies & services Forming & leading cross-functional field teams (sales, clinical, technical) Distribution channel & customer relationship management Domestic and international sales Strategic alliances GPO, and national accounts management Multiple therapeutic expertise Consumer directed health care (CDHC) Interim executive management Consulting Services

Jim Cloar joined Aspen MP in 2020 as the President and CEO of the company, with a goal of building on the successful business that Aspen MP has been and leading the organization to a new level of growth and achievement. With a career in orthopedics and spine, Jim has a track record of expanding growth opportunities and building organizations to exceptional levels of success. Jim has held increasingly more responsible positions within DePuy, Medtronic, Biomet, Synaptive Medical, and most recently, ZimmerBiomet, where he was the President of Global Spine. A strong leader, Jim has built his reputation on his ability to expand and capitalize on the commercialization strengths of an organization. Believing the opportunity at Aspen MP is to evolve the existing and past successes of the organization to a new level of accomplishment, Jim is committed to continuing the Aspen MP track record of developing innovative products that help transform the lives of people in recovery, pain management and returning to normal levels of activity. All this while continuing to focus on meeting the needs of the customer and maintaining the award-winning culture that Aspen MP has become known for enjoying.